CA1044141A - Medicament contre l'hypertension - Google Patents

Medicament contre l'hypertension

Info

Publication number
CA1044141A
CA1044141A CA233,279A CA233279A CA1044141A CA 1044141 A CA1044141 A CA 1044141A CA 233279 A CA233279 A CA 233279A CA 1044141 A CA1044141 A CA 1044141A
Authority
CA
Canada
Prior art keywords
composition
diuretic
alkyl
hydroxypropoxy
thiadiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA233,279A
Other languages
English (en)
Other versions
CA233279S (en
Inventor
Charles S. Sweet
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA1044141A publication Critical patent/CA1044141A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA233,279A 1974-08-16 1975-08-12 Medicament contre l'hypertension Expired CA1044141A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49796174A 1974-08-16 1974-08-16
US55437375A 1975-03-03 1975-03-03

Publications (1)

Publication Number Publication Date
CA1044141A true CA1044141A (fr) 1978-12-12

Family

ID=27052662

Family Applications (1)

Application Number Title Priority Date Filing Date
CA233,279A Expired CA1044141A (fr) 1974-08-16 1975-08-12 Medicament contre l'hypertension

Country Status (10)

Country Link
AU (1) AU505455B2 (fr)
CA (1) CA1044141A (fr)
CY (1) CY978A (fr)
DE (1) DE2536349A1 (fr)
FR (1) FR2281757A1 (fr)
GB (1) GB1495034A (fr)
HK (1) HK73178A (fr)
KE (1) KE2903A (fr)
MY (1) MY7900033A (fr)
NL (1) NL7508856A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192673A (en) * 1979-02-02 1984-07-06 Merck & Co Inc Ophthalmic compositions for lowering intraocular pressure
IE50901B1 (en) * 1980-03-04 1986-08-06 Merck & Co Inc Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis

Also Published As

Publication number Publication date
FR2281757A1 (fr) 1976-03-12
HK73178A (en) 1978-12-22
AU505455B2 (en) 1979-11-22
FR2281757B1 (fr) 1980-04-11
AU8371375A (en) 1977-02-10
DE2536349A1 (de) 1976-02-26
MY7900033A (en) 1979-12-31
CY978A (en) 1979-03-23
GB1495034A (en) 1977-12-14
KE2903A (en) 1978-12-01
NL7508856A (nl) 1976-02-18

Similar Documents

Publication Publication Date Title
CN100540001C (zh) 包含止泻药和埃坡霉素或埃坡霉素衍生物的组合
DE69435039T2 (de) Verwendung von thiazolidindionen zur vorbeugung oder verzögerung des auftretens des nichtinsulinabhängigen diabetes mellitus (niddm)
CA2515343A1 (fr) Terpene alcaloides antiparasitiques
EP0622076B1 (fr) Inhibiteur de restenose apres arterioplastie coronarienne percutanee
PL195140B1 (pl) Kompozycja farmaceutyczna zawierająca 5-[4-[2-(N-metylo-N-(2-pirydylo)amino)etoksy]-benzylo] tiazolidyno-2,4-dion i jej zastosowanie
EP0051706B1 (fr) Unité de dosage du type capsule de gélatine contenant du triamtérène
HK1042303A1 (zh) 新的化合物
KR20010013843A (ko) 로지글리타존 및 인슐린을 사용한 당뇨병의 치료
JP4306825B2 (ja) インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
DK159590B (da) Fremgangsmaade til forhindring af nedbrydning af thieno-pyridinderivater
KR20010013410A (fr) Composition renfermant de la 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
US4178374A (en) Novel pharmaceutical compositions of β-blockers with diuretics
MY160429A (en) 2, 5-disubstituted 3-mercaptopentanoic acid
US4238485A (en) Novel pharmaceutical compositions
JPH11302177A (ja) 腎炎治療剤
JPS62132826A (ja) 抗高血圧剤
US4952410A (en) Pharmaceutical products of moxonidine and hydrochlorothiazide
IE70332B1 (en) Antiallergic combination
US3833727A (en) Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension
US6069147A (en) Thermogenesis stimulating drugs
WO2000066550A8 (fr) Nouveaux composes
EP2517728B1 (fr) Olmesartane medoxomil pour la prévention ou le traitement des maladies oculaires angiogènes
CA1069049A (fr) COMBINAISON D'UN GROUPE PROTECTEUR EN .beta. ET D'INDANONE UTILISEE AVEC OU SANS AMILORIDE
EP0452697B1 (fr) Stabilisateur pour une préparation contenant du 4-éthyl-2-hydroxyimino-5-nitro-3-hexénamide et méthode de stabilisation
CA1172566A (fr) Methode de preparation de composes pharmaceutiques